Bipartisan Legislation Introduced to Increase Access to Biosimilars in Medicare Plans
By EsqSocial Corporation 13/05/21
On April 26, Representatives Paul D. Tonko (D-NY) and Bob Gibbs (R-OH) introduced the Star Rating for Biosimilars Act. The proposed legislation would direct the U.S. Department of Health & Human Services (HHS) to evaluate Medicare plans based on whether or not cost-saving biosimilars are available to enrollees and to evaluate Medicare Advantage and Part D plans on access to biosimilar drugs....
By: Goodwin